GEVO insider plans sale of 5,000 shares

Gevo insider Andrew Shafer has filed a Form 144 indicating an intention to sell 5,000 shares of Gevo common stock.

Accepted by SEC EDGAR 01/20/2026 - 04:18 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Gevo insider Andrew Shafer has filed a Form 144 indicating an intention to sell 5,000 shares of Gevo common stock. The shares are to be sold through broker Stifel Nicolaus & Company on the Nasdaq, with an indicated aggregate market value of $9,900.00 and an approximate sale date of 01/20/2026.

The 5,000 shares were acquired on 11/01/2024 as restricted stock units from the issuer, with cash listed as the form of payment. The filing also lists recent sales by Shafer over the past three months, including multiple transactions of 5,000 shares and a larger sale of 29,797 shares of common stock with stated gross proceeds for each transaction.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the GEVO Form 144 filing disclose?

The Form 144 filing discloses that Andrew Shafer intends to sell 5,000 shares of Gevo common stock, with an indicated aggregate market value of $9,900.00, through Stifel Nicolaus & Company on the Nasdaq.

How many GEVO shares is Andrew Shafer planning to sell under this Form 144?

Andrew Shafer is planning to sell 5,000 shares of Gevo common stock, with the filing showing an aggregate market value of $9,900.00 and an approximate sale date of 01/20/2026.

When and how did Andrew Shafer acquire the GEVO shares to be sold?

The 5,000 shares to be sold were acquired on 11/01/2024 as restricted stock units from the issuer, with the form indicating cash as the nature of payment.

What prior GEVO stock sales by Andrew Shafer are reported in the last 3 months?

The filing lists several past 3-month transactions by Andrew Shafer in Gevo common stock, including sales of 5,000 shares on 10/20/2025, 29,797 shares on 11/03/2025, 5,000 shares on 11/20/2025, and 5,000 shares on 12/22/2025, each with stated gross proceeds.

Which broker and exchange are involved in this planned GEVO share sale?

The planned sale of Gevo common stock is to be executed through Stifel Nicolaus & Company Inc., with the securities listed for sale on the Nasdaq exchange.

What class of GEVO securities is covered by this Form 144?

The Form 144 covers common stock of Gevo, with 242,308,806 shares of this class shown as outstanding in the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001999254
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Gevo, Inc.
SEC File Number	001-35073
Address of Issuer	345 INVERNESS DRIVE SOUTH, BUILDING C Suite 310 ENGLEWOOD COLORADO 80112
Phone	303-858-8358
Name of Person for Whose Account the Securities are To Be Sold	Shafer Andrew
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Stifel Nicolaus & Company Inc 501 N Broadway St. Louis MO 63102	5000	9900.00	242308806	01/20/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	11/01/2024	Restricted Stock Units	Issuer			5000	11/01/2024	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Andrew Shafer 345 Inverness Dr S Ste 310 Englewood CO 80112	Common Stock	12/22/2025	5000	10974.00
Andrew Shafer 345 Inverness Dr S Ste 310 Englewood CO 80112	Common Stock	11/20/2025	5000	9937.00
Andrew Shafer 345 Inverness Dr S Ste 310 Englewood CO 80112	Common Stock	11/03/2025	29797	67970.00
Andrew Shafer 345 Inverness Dr S Ste 310 Englewood CO 80112	Common Stock	10/20/2025	5000	12650.00

144: Remarks and Signature

Remarks
Date of Notice	01/20/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/22/2024
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Luca Lotito, as a duly authorized representative of STIFEL, as attorney-in-fact for Andrew Shafer
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)